Italian Ministry of Education, University and Research · Remote, Italia · · 35€ - 52€


Descrizione dell'offerta

Organisation/Company SAPIENZA UNIVERSITA' DI ROMA Research Field Medical sciences » Medicine Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 23 Oct 2026 - 23:59 (UTC) Country Italy Type of Contract To be defined Job Status Not Applicable Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No

Offer Description

Obesity is a chronic, multifactorial disease associated with an increased risk of metabolic complications, including hepatic steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD). Although pharmacological treatments can induce substantial weight loss and improve metabolic health, treatment response varies considerably among individuals, and the clinical and biochemical factors underlying this variability remain incompletely understood. Identifying predictors of treatment response may support a more personalized therapeutic approach. This study will investigate the association between baseline and treatment-related clinical and biochemical characteristics and the magnitude of weight loss and hepatic fat reduction in patients with obesity receiving different pharmacological treatments. The identification of reliable predictors may improve patient stratification and contribute to treatment selection and optimization in clinical practice.

  • Italy

Eligibility of fellows: country/ies of residence:

  • EUROPE

Eligibility of fellows: nationality/ies:

#J-18808-Ljbffr

Candidatura e Ritorno (in fondo)

Candidati ora

Salva questo annuncio

Accedi o registrati (gratis) per salvarlo nei preferiti e ritrovarlo quando vuoi.

Accedi Registrati gratis
Torna all'elenco

Ricevi annunci simili

Inserisci la tua email: ti avvisiamo quando escono nuovi annunci corrispondenti.

Nessun account necessario. Disiscrizione con un clic dall'email.